<DOC>
	<DOCNO>NCT00250172</DOCNO>
	<brief_summary>The purpose study measure particular protein brain call phosphodiesterase use image technique positron emission tomography ( PET ) magnetic resonance imaging ( MRI ) .</brief_summary>
	<brief_title>PET Whole Body Biodistribution Test Retest Bain Imaging Studies Using Phosphodiesterase 4 Inhibitor ( R ) -11CRolipram</brief_title>
	<detailed_description>Both basic clinical study indicate 3 ' , 5'-cyclic adenosine monophosphate ( cAMP ) system play critical role several brain disease , particularly mood disorder drug addiction . cAMP synthesize adenosine 5'-triphosphate ( ATP ) adenylyl cyclase metabolize cyclic nucleotide phosphodiesterases ( PDEs ) . Among component cAMP pathway , PDE4 appear critical antidepressant effect . 4- [ 3- ( cyclopentoxyl ) -4-methoxyphenyl ] -2-pyrrolidone ( rolipram ) inhibitor PDE4 . As positron emission tomography ( PET ) brain imaging agent , rolipram good property high affinity 1-2 nM appropriate lipophilicity ( Log P ) ~3 . A rat study give estimation low radiation absorb dos active enantiomer ( R ) - [ 11C ] rolipram . ciociWEge quality . Therefore , R- [ 11C ] rolipram promise PET ligand . However , radiation absorb dos estimate human whole body image study method measure binding ( R ) - [ 11C ] rolipram human brain establish . &lt; TAB &gt; The purpose protocol estimate radiation absorb dos ( R ) - [ 11C ] rolipram perform whole body image study healthy human subject also establish accurate method measure PDE4 level brain perform test retest brain imaging study . The result overall study require apply PET ligand various neurological psychiatric disorder future .</detailed_description>
	<mesh_term>Phosphodiesterase 4 Inhibitors</mesh_term>
	<mesh_term>Rolipram</mesh_term>
	<criteria>INCLUSION CRITERIA : All subject must healthy age 18 65 year . EXCLUSION CRITERIA : PART 1 ( WHOLE BODY IMAGING STUDIES ) : 1 . Current psychiatric disease , substance abuse severe systemic disease base history physical exam , poor vision hearing . 2 . Laboratory test clinically significant abnormality . 3 . Prior participation research protocols clinical care last year radiation exposure include protocol would exceed half annual limit . Because human dosimetry ( R ) [ ( 11 ) C ] rolipram estimate use rhesus monkey , total exposure include ( R ) [ ( 11 ) C ] rolipram whole body image study limit half RSC guideline . 4 . Pregnancy breast feed . 5 . Positive HIV test . 6 . Positive urine drug screen . PART 2 ( TEST RETEST BRAIN IMAGING STUDIES ) : 1 . Current psychiatric disease , substance abuse severe systemic disease base history physical exam , poor vision hearing . 2 . Laboratory test clinically significant abnormality . 3 . Prior participation research protocols clinical care last year radiation exposure would exceed annual limit . Results part 1 use calculate total radiation exposure within year . 4 . Pregnancy breast feed . 5 . Claustrophobia . 6 . Presence ferromagnetic metal body heart pacemaker . 7 . Positive HIV test . 8 . A history brain disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 15, 2014</verification_date>
	<keyword>Dosimetry</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Compartment Analysis</keyword>
	<keyword>Reproducibility</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>